menu

Loading...

NUS Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

8.379

Open

8.250

VWAP

8.17

Vol

767.91K

Mkt Cap

388.86M

Low

8.060

Amount

6.28M

EV/EBITDA(TTM)

2.73

Total Shares

48.13M

EV

392.46M

EV/OCF(TTM)

4.89

P/S(TTM)

0.29

Nu Skin Enterprises Inc. develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. It has nine segments, consisting of its seven geographic Nu Skin segments - Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan - and two Rhyz segments - Manufacturing and Rhyz Other. Its brands include Nu Skin personal care, Pharmanex nutrition and ageLOC anti-aging. Its skin and beauty solutions include acne and blemishes, anti-aging, dark circles and puffiness, discoloration, dry skin, lifting and firming, lines and wrinkles, and oily skin and pores. Its nutrition solutions include bone and joint health, brain and memory, energy and stamina, heart health, immunity support, nail skin and hair health, and women's health. It offers various beauty devices, including ageLOC Rose Gold LumiSpa iO, ageLOC LumiSpa Silicone Head, ageLOC LumiSpa iO Stand and LumiSpa Rose Gold Accent Twin Pack.

Show More

Events Timeline

(ET)

2026-02-12

16:20:00

Sees FY26 Revenue of $1.35B to $1.50B

2026-02-12

16:10:00

Sees Q2 Revenue of $320M to $340M

2026-02-12

16:10:00

Nu Skin Reports Q4 Revenue of $370.3M

2025-11-06 (ET)

2025-11-06

16:28:39

Nu Skin projects FY25 EPS between $3.15 and $3.25

2025-11-06

16:28:12

Nu Skin Projects Q4 EPS Between 25c and 35c

2025-11-06

16:27:43

Nu Skin Announces Q3 EPS of 34 Cents, Up from 17 Cents Last Year

2025-08-07 (ET)

2025-08-07

16:51:14

Nu Skin sees FY25 EPS $3.05-$3.25

2025-08-07

16:48:04

Nu Skin reports Q2 EPS 43c vs. ($2.38) last year

2025-05-08 (ET)

2025-05-08

17:11:02

Nu Skin reports Q1 EPS 23c excluding Mavely gain vs. 9c last year

2025-02-14 (ET)

2025-02-14

12:00:37

Nu Skin rises 22.6%

News

Benzinga

Pinterest Misses Q4 Revenue Expectations

Benzinga

Oversold Stocks in Consumer Staples Present Buying Opportunities

Benzinga

Nu Skin Misses Earnings Expectations, Shares Drop Significantly

seekingalpha

02-13seekingalpha

Nu Skin Reports Strong Q4 2025 Earnings and Strategic Growth Plans

seekingalpha

02-12seekingalpha

Nu Skin Q4 Earnings Miss Expectations, Shares Drop

seekingalpha

02-11seekingalpha

Nu Skin to Announce Q4 Earnings on February 12

Valuation Metrics

The current forward P/E ratio for NU Skin Enterprises Inc (NUS.N) is 7.34, compared to its 5-year average forward P/E of 12.18. For a more detailed relative valuation and DCF analysis to assess NU Skin Enterprises Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

5Y Average PE

12.18

Current PE

7.34

Overvalued PE

16.78

Undervalued PE

7.58

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

6.06

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

8.96

Undervalued EV/EBITDA

3.15

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

0.63

Current PS

0.31

Overvalued PS

0.96

Undervalued PS

0.29

Financials

AI Analysis

Annual

Quarterly

Whales Holding NUS

Castleknight Management LP

Trading Trends

People Also Watch

Frequently Asked Questions

What is NU Skin Enterprises Inc (NUS) stock price today?

The current price of NUS is 8.08 USD — it has decreased -4.72

What is NU Skin Enterprises Inc (NUS)'s business?

Nu Skin Enterprises Inc. develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. It has nine segments, consisting of its seven geographic Nu Skin segments - Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan - and two Rhyz segments - Manufacturing and Rhyz Other. Its brands include Nu Skin personal care, Pharmanex nutrition and ageLOC anti-aging. Its skin and beauty solutions include acne and blemishes, anti-aging, dark circles and puffiness, discoloration, dry skin, lifting and firming, lines and wrinkles, and oily skin and pores. Its nutrition solutions include bone and joint health, brain and memory, energy and stamina, heart health, immunity support, nail skin and hair health, and women's health. It offers various beauty devices, including ageLOC Rose Gold LumiSpa iO, ageLOC LumiSpa Silicone Head, ageLOC LumiSpa iO Stand and LumiSpa Rose Gold Accent Twin Pack.

What is the price predicton of NUS Stock?

Wall Street analysts forecast NUS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NUS is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is NU Skin Enterprises Inc (NUS)'s revenue for the last quarter?

NU Skin Enterprises Inc revenue for the last quarter amounts to 370.32M USD, decreased -16.89

What is NU Skin Enterprises Inc (NUS)'s earnings per share (EPS) for the last quarter?

NU Skin Enterprises Inc. EPS for the last quarter amounts to 0.29 USD, decreased -139.73

How many employees does NU Skin Enterprises Inc (NUS). have?

NU Skin Enterprises Inc (NUS) has 2800 emplpoyees as of March 03 2026.

What is NU Skin Enterprises Inc (NUS) market cap?

Today NUS has the market capitalization of 388.86M USD.